Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses.

Background: Little is known about the vaccine effectiveness (VE) in attenuating the influenza-associated symptoms in children during the 2014-2015 influenza season in Beijing, China, in which there was a mismatch between the vaccine and circulating strain. Methods: This study included 210 laboratory-confirmed influenza cases among children, who were enrolled in 2014, from November 1 to December 31. Standard demographic information and clinical symptoms were recorded. Influenza vaccination was confirmed via a vaccination registry. Univariate and multivariate analyses were used to estimate the odds of presenting with clinical symptoms among vaccinated and unvaccinated groups, adjusting for sex, age, area, BMI level, and chronic conditions. Results: Among the 210 laboratory-confirmed influenza cases, 170 (81.0%) presented with fever >= 38 degrees C. The other most common symptoms were cough (78.1%), sore throat (46.7%), nasal congestion/rhinorrhea (38.6%), headache (34.8%), fatigue (24.8%) and myalgia/arthralgia (16.2%). Approximately 9.0% (19/210) exhibited nausea/vomiting, and 2.4% (5/210) exhibited diarrhea/abdominal pain. Respiratory complications occurred in 5.7% (12/210) of the confirmed influenza cases. In 210 laboratory-confirmed cases, univariate and multivariate conducted after adjusted for the aforementioned characteristics suggested that the odds of fever >= 38 degrees C were significantly reduced in vaccinated children (odds ratio [OR]: 0.42, 95% CI: 0.19-0.93; P = 0.033). Conclusions: Influenza vaccination may reduce the clinical symptoms of laboratory-confirmed influenza cases potentially even in the mismatching season.